Intranasal vaccination with recombinant outer membrane protein CD and adamantylamide dipeptide as the mucosal adjuvant enhances pulmonary clearance of Moraxella catarrhalis in an experimental murine model
about
Current progress with Moraxella catarrhalis antigens as vaccine candidatesComprehensive antigen screening identifies Moraxella catarrhalis proteins that induce protection in a mouse pulmonary clearance modelATP-Binding Cassette (ABC) Transporters of the Human Respiratory Tract Pathogen, Moraxella catarrhalis: Role in VirulencePanel 6: Vaccines.Substrate binding protein SBP2 of a putative ABC transporter as a novel vaccine antigen of Moraxella catarrhalis.Vaccine targets against Moraxella catarrhalis.Secondary electrospray ionization-mass spectrometry (SESI-MS) breathprinting of multiple bacterial lung pathogens, a mouse model study.Needle-free vaccine delivery.Use of the Chinchilla model to evaluate the vaccinogenic potential of the Moraxella catarrhalis filamentous hemagglutinin-like proteins MhaB1 and MhaB2.Current progress of adhesins as vaccine candidates for Moraxella catarrhalis.Mucosal vaccination against bacterial respiratory infections.Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis.Mucosal immunity and nasal influenza vaccination.Moraxella catarrhalis: from interactions with the host immune system to vaccine development.Bactericidal, opsonophagocytic and anti-adhesive effectiveness of cross-reactive antibodies against Moraxella catarrhalis.Potential impact of a Moraxella catarrhalis vaccine in COPD.A Cation-binding Surface Protein as a Vaccine Antigen to Prevent Moraxella catarrhalis Otitis Media and Infections in Chronic Obstructive Pulmonary Disease.Immunoinformatics Identifies a Lactoferrin Binding Protein A Peptide as a Promising Vaccine With a Global Protective Prospective Against Moraxella catarrhalis.Characterization and evaluation of the Moraxella catarrhalis oligopeptide permease A as a mucosal vaccine antigen.Contribution of Moraxella catarrhalis type IV pili to nasopharyngeal colonization and biofilm formation.
P2860
Q28304447-BBE39201-C7EE-4873-9958-97E4CEAEDD5CQ28382833-EE03A008-6F4F-46A0-B7F7-3863353092F1Q28552490-FE3EF2D1-A82C-4DF4-8152-D814ED4E49E4Q33644678-12F7BD1D-266F-4AFF-9F08-92576BB7027DQ34058997-7D705403-6946-4FB3-99C8-A2F6755213B1Q36483998-C29AA848-4665-45B4-8665-7F2EB0E8990DQ36924171-41774C70-ABDC-4679-9E1A-5E81A9169BB2Q36945838-7CAB38E2-B457-4A83-A877-1AA5915DA584Q36976255-16F2B932-5323-4A23-9C2A-5A70F27356D8Q37123450-9B2FED1C-728F-47D4-AA01-A62843B937B1Q37290114-F2B4DE7C-42DC-4A94-A6B1-0DDFC86B693EQ37441243-D17FC61A-4FE2-4E82-AA7E-9B7DB30A29F2Q38028996-6738BED3-AFC4-48FF-A3A9-C40397D78D26Q38041190-DA67C67D-3A2A-417F-8444-DD04DAA8E7F3Q38903194-6C471785-1B4B-4AF2-884C-EC7540442EF9Q39129692-DEAD864E-DE6E-43C8-B5AA-8C7F859EEF2BQ40154497-855ABFF1-F267-499C-B568-E08457DD3422Q40780023-26D6BDD6-77A9-4B12-8324-58B0ADD8D92BQ42583054-147EAB11-63CC-4C5F-BC6F-79417D865B09Q42909736-98BA84E8-4F18-4052-BA4D-12C3247400EE
P2860
Intranasal vaccination with recombinant outer membrane protein CD and adamantylamide dipeptide as the mucosal adjuvant enhances pulmonary clearance of Moraxella catarrhalis in an experimental murine model
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Intranasal vaccination with re ...... n an experimental murine model
@en
type
label
Intranasal vaccination with re ...... n an experimental murine model
@en
prefLabel
Intranasal vaccination with re ...... n an experimental murine model
@en
P2093
P2860
P356
P1476
Intranasal vaccination with re ...... n an experimental murine model
@en
P2093
Carlos A Guzmán
David Souss
Gustavo M Bertot
Pablo D Becker
Saúl Grinstein
Thomas Ebensen
P2860
P304
P356
10.1128/IAI.01081-06
P407
P577
2006-11-13T00:00:00Z